Roy D. Baynes

Director, Travere Therapeutics, Inc.

Companies

Eikon Therapeutics, Inc.Chief Medical Officer Feb 4, 2026 to now¹
Nurix (United States)Board member Mar 13, 2025 to now²
Aardvark Therapeutics, Inc.Board member Feb 12, 2025 to now³
NateraBoard member Aug 2, 2018 to now⁴
Travere Therapeutics, Inc.Board member Jul 26, 2016 to now⁵
Atara Biotherapeutics, Inc.Board member Sep 12, 2018 to Jun 27, 2022⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREikon Therapeutics, Inc., Chief Medical Officer
2
SEC EDGARNurix (United States), Board member
3
SEC EDGARAardvark Therapeutics, Inc., Board member
4
SEC EDGARNatera, Board member
5
SEC EDGARTravere Therapeutics, Inc., Board member
6
SEC EDGARAtara Biotherapeutics, Inc., Board member